Search Login Register

Tamoxifen Summary

Description: One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.

Also Known As: ICI-46,474; ICI-46474; ICI-47699; Nolvadex; Novaldex Show All >>

Networked: 10496 relevant articles (1116 outcomes, 2707 trials/studies) for this Drug

Key Diseases for which Tamoxifen is Relevant

  1. Breast Neoplasms (Breast Cancer) : 704 outcomes 1853 studies in 6847 results
  2. Neoplasms (Cancer) : 243 outcomes 401 studies in 2537 results
  3. Carcinoma (Carcinomatosis) : 34 outcomes 110 studies in 651 results
  4. Neoplasm Metastasis (Metastasis) : 34 outcomes 30 studies in 280 results
  5. Endometrial Neoplasms (Endometrial Cancer) : 30 outcomes 120 studies in 712 results
Show All >>

Drugs Related to Tamoxifen

  1. Estrogens (Estrogen)
  2. Hormones
  3. Aromatase Inhibitors
  4. anastrozole (Arimidex)
  5. letrozole (Femara)
  6. Estrogen Receptor Modulators (Antiestrogen)
  7. exemestane (Aromasin)
  8. Raloxifene (Evista)
  9. Selective Estrogen Receptor Modulators (SERM)
  10. Aromatase (CYP19)
Show All >>

Therapies Related to Tamoxifen

  1. Drug Therapy (Chemotherapy)
  2. Chemoprevention
  3. Radiotherapy
  4. Heterologous Transplantation (Xenotransplantation)
  5. Segmental Mastectomy (Lumpectomy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.